| PERIOD ENDING | 28-Dec-08 | 30-Dec-07 | 31-Dec-06 | | Total Revenue | 2,281,803 | 2,500,813 | 2,579,274 | | Cost of Revenue | 2,193,345 | 2,065,143 | 2,066,642 | | | Gross Profit | 88,458 | 435,670 | 512,632 | | | Operating Expenses | | Research Development | 431,808 | 436,785 | 347,740 | | Selling General and Administrative | 253,878 | 239,317 | 255,648 | | Non Recurring | 1,674,583 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,271,811) | (240,432) | (90,756) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,200 | 32,595 | 11,681 | | Earnings Before Interest And Taxes | (2,266,611) | (207,837) | (79,075) | | Interest Expense | 97,843 | 80,803 | 70,903 | | Income Before Tax | (2,364,454) | (288,640) | (149,978) | | Income Tax Expense | 62,865 | (25,144) | (2,215) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,427,319) | (263,496) | (147,763) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,427,319) | (263,496) | (147,763) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,427,319) | ($263,496) | ($147,763) |
|
1.52% Nasdaq 
Income Statement
